Skip to main content
Clinical Trials/NCT03859492
NCT03859492
Completed
Not Applicable

Screening Contrast Enhanced Mammography (CEDM) in Intermediate and High-Risk Patient Populations

Mayo Clinic1 site in 1 country461 target enrollmentStarted: February 15, 2019Last updated:
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Status
Completed
Enrollment
461
Locations
1
Primary Endpoint
Breast Cancer

Overview

Brief Summary

This research study is being done to determine if Contrast Enhanced Digital Mammography (CEDM) can improve breast cancer detection and can be used as an additional screening method to the standard mammographic screening.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
35 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women aged 35 and had a negative routine mammogram within 6 months.
  • Qualifies as intermediate or high-risk (\>15% lifetime risk of breast cancer as defined by IBIS version 8).

Exclusion Criteria

  • Known breast cancer
  • Previously had negative MBI or MRI within 12 months of study
  • Pregnant or lactating
  • Contraindication to intravenous iodinated contrast
  • Unable to understand or sign informed consent
  • Self-reported signs or symptoms of breast cancer

Outcomes

Primary Outcomes

Breast Cancer

Time Frame: 3 years

Number of subjects diagnosed with breast cancer

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Bhavika Patel

Principal Investigator

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials